England cancer plan: 75% five-year survival by 2035

England has a new National Cancer Plan for England. The government says the NHS will get faster at diagnosing and treating cancer, with a headline promise that from 2035 three in four people diagnosed will be cancer‑free or living well five years on. There is also a pledge to meet all cancer waiting‑time standards by March 2029. We break down what that means in real life.

Five‑year survival is a simple yardstick: if you are diagnosed in a given year, are you alive five years later, and how well are you living? Right now, around 60% do reach five years, and about 2.4 million people in England are living after a cancer diagnosis. The plan’s ambition lifts that figure to 75%, which the Department of Health and Social Care says could mean roughly 320,000 extra lives saved over the life of the plan.

Why this matters is clear. The NHS has not hit its central cancer performance measure-85% starting treatment within 62 days of an urgent referral-since 2014. For some cancers, England trails countries you might not expect, including Romania and Poland. The plan is pitched as a reset to catch up and then move ahead.

Waiting‑time standards can feel like jargon, so here’s the plain‑English version. If your GP makes an urgent referral, the 62‑day standard measures the time to your first treatment. The government says the NHS will meet all cancer waiting‑time standards by March 2029, which it believes will mean hundreds of thousands more people beginning treatment within 62 days. Faster starts usually mean better outcomes.

The plan puts serious weight behind diagnosis. A £2.3 billion investment is earmarked for scanners, digital systems and automated testing, with the aim of delivering 9.5 million extra tests by 2029. Community Diagnostic Centres will open for longer-twelve hours a day, seven days a week-so more people can get scans and checks close to home and outside working hours.

Surgery is set to change too. Robot‑assisted procedures across the NHS are planned to rise from about 70,000 to 500,000 by 2035. A surgeon still makes every clinical decision, but works via precise robotic arms. The promise is fewer complications, smaller incisions, and shorter hospital stays-freeing beds and helping people recover sooner.

Genomic testing will be offered to everyone who could benefit. That means analysing the DNA of a person’s cancer to understand its exact type and the mutations driving it. Clinicians can then match people to targeted drugs or clinical trials more likely to work for their specific tumour. If you or someone you support is starting treatment, it’s reasonable to ask whether a genomic test is appropriate.

For rarer and less common cancers, care will increasingly be reviewed and delivered in specialist centres. These bring surgeons, oncologists, radiologists and specialist nurses around one plan for each person. Patient groups such as Cancer52 have pushed for this focus for years; the plan and the Rare Cancers Bill are presented as a step towards parity for people with less common diagnoses.

There are pilots and practical supports alongside the big targets. An AI project aims to spot hard‑to‑reach lung cancers earlier and with fewer invasive tests. A new partnership with employers is intended to help England’s 830,000 working‑age people living with cancer stay in, or return to, work-recognising that money, routine and dignity matter during treatment and recovery.

Leaders across the system say the direction is right. Health and Social Care Secretary Wes Streeting frames the plan as making world‑class care available to everyone, not just the lucky few. NHS England’s cancer lead, Professor Peter Johnson, talks about earlier diagnosis, on‑time treatment and wider access to trials. Macmillan Cancer Support, Cancer Research UK, Cancer52 and Maggie’s all welcome the ambition while warning that delivery will take sustained effort.

Here’s how you can use this information if you are a patient or carer. Keep a note of referral dates and ask your team what timeline to expect for tests and first treatment. If travel is a barrier, ask about Community Diagnostic Centres or evening and weekend slots. If you are offered surgery, ask whether a robot‑assisted approach is suitable. For drug treatment, ask whether genomic testing could guide choices. If you work, speak early to your employer about adjustments and phased returns-support is part of the plan.

A quick media‑literacy check helps us read the promises well. Targets are not care in themselves; they are tools to steer staffing, equipment and money. Watch the dates-March 2029 for waiting‑time standards and 2035 for the survival ambition-and look for regular data showing progress. The government also points to wider prevention measures, including a proposed generational ban on smoking and restrictions on junk food advertising before 9pm. As teachers, students and families, we should keep asking the practical question: are more people getting diagnosed sooner and starting treatment on time? That’s the change that saves lives.